Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -16.23% vs 13.28% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is -43.65% vs 18.05% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -51.32% vs 18.32% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 163.64% vs 29.41% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Pacific Shuanglin Bio-pharmacy Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.25% vs 63.32% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -16.23% vs 13.28% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -17.28% vs 65.35% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -43.65% vs 18.05% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -33.15% vs 51.55% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -51.32% vs 18.32% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 65.71% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 163.64% vs 29.41% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






